Related Experiment Video
Updated: Jun 2, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Biologics in rheumatoid arthritis--recommendations for Swiss practice
Jean Dudler1, Burkhard Möller, Beat A Michel
1Department of Rheumatology, University Hospital Lausanne, Switzerland. jean.dudler@chuv.ch
Abstract:
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Rheumatic Heart Disease III: Medical Management
Drug Products: Biologics, Biosimilars and Interchangeables
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...